Regina Lin

Regina Lin

Company: Allogene

Job title: Principle Scientist

Seminars:

Preclinical Evaluation of ALLO-605, an Allogeneic BCMA TurboCAR T Cell Therapy for the Treatment of Multiple Myeloma 10:30 am

ALLO-605 bears a Turbodomain that confers constitutive, CAR T cellintrinsic cytokine signaling ALLO-605 demonstrated increased potency and persistence, while maintaining a good safety profile Analyze these preclinical results and how they support clinical investigation of ALLO-605 for the treatment of multiple myelomaRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.